SEARCH

SEARCH BY CITATION

References

  • Barria A., Muller D., Derkach V., Griffith L. C. and Soderling T. R. (1997) Regulatory phosphorylation of AMPA-type glutamate receptor by CaM-KII during long-term potentiation. Science 276, 20422045.
  • Baxter M. G., Lanthorn T. H., Frink K. M., Golski S., Wan R. and Olton D. S. (1994) d-Cycloserine, a novel cognitive enhancer, improves spatial memory in aged rats. Neurobiol. Aging 15, 207213.
  • Bliss T. V. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 3139.
  • Derkach V., Barria A. and Soderling T. R. (1999) Ca2+/calmodulin-kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors. Proc. Natl Acad. Sci. USA 96, 32693274.
  • Dysken M. W., Mendels J. and LeWitt P. (1992) Milacemide; a placebo-controlled study in senile dementia of the Alzheimer type. Am. J. Geriatr. Psychiatry 40, 503506.
  • Edwards S., Simmons D. L., Galindo D. G., Doherty J. M., Scott A. M., Hughes P. D. and Wilcox R. E. (2002) Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor. Alcoholism 26, 173180.
  • Fley U., Huang Y. Y. and Kandel E. R. (1993) Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260, 16611664.
  • Fukunaga K. and Miyamoto E. (2000) A working model of CaM Kinase II activity in hippocampal long-term potentiation and memory. Neurosci. Res. 38, 317.
  • Fukunaga K., Goto S. and Miyamoto E. (1988) Immunohistochemical localization of Ca2+/calmodulin-dependent protein kinase II in rat brain and various tissues. J. Neurochem. 51, 10701078.
  • Fukunaga K., Soderling T. R. and Miyamoto E. (1992) Activation of Ca2+/calmodulin-dependent protein kinase II and protein kinase C by glutamate in cultured rat hippocampal neurons. J. Biol. Chem. 267, 2252722533.
  • Fukunaga K., Stoppini L., Miyamoto E. and Muller D. (1993) Long-term potentiation is associated with an increased activity of Ca2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 268, 78637867.
  • Fukunaga K., Muller D. and Miyamoto E. (1995) Increased phosphorylation of Ca2+/calmodulin-dependent protein kinase II and its endogenous substrates in the induction of long term potentiation. J. Biol. Chem. 270, 61196124.
  • Giacobini E. (2000) Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer’s disease. Alzheimer Dis. Assoc. Disorders 14 (Suppl. 1), S3S10.
  • Greenamyre J. T., Penney J. B., D’Amato C. J. and Young A. B. (1987) Dementia of the Alzheimer’s type: changes in hippocampal L-[3H]glutamate binding. J. Neurochem. 48, 543551.
  • Hanndelmann G. E., Nevins M. E., Mueller L. L., Arnolde S. M. and Cordi A. A. (1989) Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic reodents. Pharmacol. Biochem. Behav. 34, 823828.
  • Kamphuis W., Hendriksen E. and Lopes da Silva F. H. (1995) Isozyme specific changes in the expression of protein kinase C isozyme (alpha–zeta) genes in the hippocampus of rats induced by kindling epileptogenesis. Brain Res. 702, 94100.
  • Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680685.
  • Lisman J., Schulman H. and Cline H. (2002) The molecular basis of CaMKII function in synaptic and behavioral memory. Nat. Rev. Neurosci. 3, 175190.
  • Liu J., Fukunaga K., Yamamoto H., Nishi K. and Miyamoto E. (1999) Differential roles of Ca2+/calmodulin-dependent protein kinase II and mitogen-activated protein kinase activation in hippocampal long-term potentiation. J. Neurosci. 19, 82928299.
  • Lledo P. M., Hjelmstad G. O., Mukherji S., Soderling T. R., Malenka R. C. and Nicoll R. A. (1995) Calcium/calmodulin-dependent kinase II and long-term potentiation enhance synaptic transmission by the same mechanism. Proc. Natl Acad. Sci. USA 92, 1117511179.
  • Lovinger D. M., Wong K. L., Murakami K. and Routtenberg A. (1987) Protein kinase C inhibitors eliminate hippocampal long-term potentiation. Brain Res. 436, 177183.
  • Lynch G., Kessler M., Arai A. and Larson J. (1990) The nature and causes of hippocampal long-term potentiation. Prog. Brain Res. 83, 233250.
  • Maelicke A. and Albuquerque E. X. (2000) Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer’s disease. Eur. J. Pharmacol. 393, 165170.
  • Maelicke A., Samochocki M., Jostock R., Fehrenbacher A., Ludwig L., Albuquerque E. X. and Zerlin M. (2001) Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer’s disease. Biol. Psychiatry 49, 279288.
  • Malenka R. C. and Nicoll R. A. (1999) Long-term potentiation – a decade of progress? Science 285, 18701874.
  • Mammen A. L., Kameyama K., Roche K. W. and Huganir R. L. (1997) Phosphorylation of the alpha-amino-3-hydroxy-5-methylisoxazole4-propionic acid receptor GluR1 subunit by calcium/calmodulin-dependent kinase II. J. Biol. Chem. 272, 3252832533.
  • Moriguchi S., Marszalec W., Zhao X., Yeh J. Z. and Narahashi T. (2003) Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons. J. Pharmacol. Exp. Ther. 307, 160167.
  • Moriguchi S., Marszalec W., Zhao X., Yeh J. Z. and Narahashi T. (2004) Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons. J. Pharmacol. Exp. Ther. 310, 933942.
  • Moriguchi S., Shioda N., Maejima H., Zhao X., Marszalec W., Yeh J. Z., Fukunaga K. and Narahashi T. (2007) Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor. Mol. Pharmacol. 71, 580587.
  • Nabeshima T. (1994) Ameliorating effects of nefiracetam (DM-9384) on brain dysfunction. Drugs Today 30, 357379.
  • Nabeshima T., Nakayama S., Ichihara K., Yamada K., Shiotani T. and Hasegawa T. (1994) Effects of nefiracetam on drug-induced impairment of latent learning in mice in a water finding task. Eur. J. Pharmacol. 255, 5765.
  • Nishizaki T., Matsuoka T., Nomura T., Matsuyama S., Watabe S., Shiotani T. and Yoshii M. (1999) A ‘long-term-potentiation-like’ facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam. Brain Res. 826, 281288.
  • Ohmitsu M., Fukunaga K., Yamamoto H. and Miyamoto E. (1999) Phosphorylation of myristoylated alanine-rich protein kinase C substrate by mitogen-activated protein kinase in cultured rat hippocampal neurons following stimulation of glutamate receptors. J. Biol. Chem. 274, 408417.
  • Roche K. W., O’Brien R. J., Mammen A. L., Bernhardt J. and Huganir R. L. (1996) Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16, 11791188.
  • Santos M. D., Alkondon M., Pereira E. F., Aracava Y., Eisenberg H. M., Maelicke A. and Albuquerque E. X. (2002) The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol. Pharmacol. 61, 12221234.
  • Schrattenholz A., Pereira E. F. R., Roth U., Weber K. H., Albuquerque E. X. and Maelicke A. (1996) Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 49, 16.
  • Schwartz B. L., Hashtroudi S., Herting R. L., Handerson H. and Deutch S. I. (1991) Glycine prodrug facilitates momory retrieval in humans. Neurology 41, 13411343.
  • Schwartz B. L., Hashtroudi S., Herting R. L., Schwartz P. and Deutsch S. I. (1996) d-Cycloserine enhances implicit memory in Alzheimer’s patients. Neurology 46, 420424.
  • Sieber F. E., Traystman R. J., Brown P. R. and Martin L. J. (1998) Protein kinase C expression and activity after global incomplete cerebral ischemia in dogs. Stroke 29, 14451452.
  • Soderling T. R. and Derkach V. A. (2000) Postsynaptic protein phosphorylation and LTP. Trends Neurosci. 23, 7580.
  • Tingley W. G., Roche K. W., Thompson A. K. and Huganir R. L. (1993) Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature 364, 7073.
  • Tingley W. G., Ehlers M. D., Kameyama K., Doherty C., Ptak J. B., Riley C. T. and Huganir R. L. (1997) Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J. Biol. Chem. 272, 51575166.
  • Vanhoose A. M. and Winder D. G. (2003) NMDA and beta-1 adrenergic receptors differently signal phosphorylation of glutamate receptor type 1 in area CA1 of hippocampus. J. Neurosci. 23, 58275834.
  • Wafford K. A., Kathoria M., Bain C. J., Marshall G., Le Bourdelles B., Kemp J. A. and Whiting P. J. (1995) Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site. Mol. Pharmacol. 47, 374380.
  • Yamagata Y. (2003) New aspects of neurotransmitter release and exocytosis: dynamic and differential regulation of synapsin I phosphorylation by acute neuronal excitation in vivo. J. Pharmacol. Sci. 93, 2229.
  • Yoshii M., Watabe S., Sakurai T. and Shiotani T. (1997) Cellular mechanism of underlying cognition-enhancing actions of nefiracetam (DM-9384). Behav. Brain Res. 83, 185188.
  • Zhao X., Kuryatov A., Lindstorm J. M., Yeh J. Z. and Narahashi T. (2001) Nootropic drug modulation of neuronal nicotinic acethylcholine receptors in rat cortical neurons. Mol. Pharmacol. 59, 674683.